Portfolio (Quarterly)
Guide ↗
MPM BIOIMPACT LLC
· CIK 0001687078| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CGEM | Cullinan Therapeutics, Inc. | Healthcare | 7,648,268.0 | $79.2M | 9.06% | NEW | — | $10.35 | +35.1% |
| 2 | MDGL | Madrigal Pharmaceuticals Inc | Healthcare | 96,780.0 | $56.4M | 6.45% | NEW | — | $582.34 | -11.8% |
| 3 | LQDA | Liquidia Corp | Healthcare | 1,400,869.0 | $48.3M | 5.53% | NEW | — | $34.49 | +79.7% |
| 4 | TRVI | Trevi Therapeutics Inc | Healthcare | 3,287,087.0 | $41.2M | 4.71% | NEW | — | $12.52 | +10.9% |
| 5 | EWTX | Edgewise Therapeutics Inc | Healthcare | 1,655,256.0 | $41.1M | 4.70% | NEW | — | $24.82 | +31.7% |
| 6 | RVMD | Revolution Medicines, Inc. | Healthcare | 505,672.0 | $40.3M | 4.61% | NEW | — | $79.65 | +88.7% |
| 7 | AGIO | Agios Pharmaceuticals Inc | Healthcare | 1,303,373.0 | $35.5M | 4.06% | NEW | — | $27.22 | +5.8% |
| 8 | QURE | Uniqure NV | Healthcare | 1,381,628.0 | $33.1M | 3.78% | NEW | — | $23.93 | +2.8% |
| 9 | PTCT | PTC Therapeutics Inc | Healthcare | 430,013.0 | $32.7M | 3.74% | NEW | — | $75.96 | -6.5% |
| 10 | SNDX | Syndax Pharmaceuticals Inc | Healthcare | 1,337,702.0 | $28.1M | 3.22% | NEW | — | $21.01 | -4.2% |
| 11 | DYN | Dyne Therapeutics, Inc. | Healthcare | 1,405,388.0 | $27.5M | 3.15% | NEW | — | $19.56 | -11.2% |
| 12 | TARS | Tarsus Pharmaceuticals Inc | Healthcare | 328,869.0 | $26.9M | 3.08% | NEW | — | $81.88 | -20.9% |
| 13 | STOK | Stoke Therapeutics Inc | Healthcare | 770,289.0 | $24.4M | 2.80% | NEW | — | $31.74 | -4.5% |
| 14 | ALMS | Alumis Inc | Healthcare | 2,401,992.0 | $23.4M | 2.68% | NEW | — | $9.76 | +127.2% |
| 15 | URGN | Urogen Pharma Ltd | Healthcare | 941,378.0 | $22.0M | 2.52% | NEW | — | $23.42 | +29.0% |
| 16 | XENE | Xenon Pharmaceuticals Inc | Healthcare | 485,620.0 | $21.8M | 2.49% | NEW | — | $44.82 | +22.0% |
| 17 | PVLA | Palvella Therapeutics Inc | Healthcare | 205,745.0 | $21.5M | 2.46% | NEW | — | $104.67 | +10.3% |
| 18 | NTRA | Natera Inc | Healthcare | 93,551.0 | $21.4M | 2.45% | NEW | — | $229.09 | -11.1% |
| 19 | CRVS | Corvus Pharmaceuticals Inc | Healthcare | 2,743,671.0 | $21.1M | 2.42% | NEW | — | $7.70 | +69.9% |
| 20 | — | DBV Technologies S A | — | 996,825.0 | $19.1M | 2.19% | NEW | — | $19.17 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%